Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LifeOS Genomics has developed the QLoci System—a highly multiplexed digital PCR-based liquid biopsy platform. Their NIPT assay panel detects major chromosomal abnormalities from maternal blood. The EGFR T790M Mutation Detection Assay Kit has been clinically validated and registered as a Laboratory Developed Test by the Taiwan FDA. Clinical trials are ongoing to further validate its performance in lung cancer patient plasma samples. The company’s technology enables sensitive detection of low-frequency mutations and broad biomarker panels with applications across prenatal testing and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LifeOS Genomics.